Innovations in Brain Tumor Management

Memorial Sloan Kettering Cancer Center, in collaboration with the National Brain Tumor Society, present Innovations in Brain Tumor Management. The overall objective of this course is to provide an up-to-date review of brain cancer. Day 1 will focus on the Innovations in Brain Tumor Management for practitioners. Day 2 will focus on Living with a Brain Tumor, a multidisciplinary review of care and services available at MSK. Please note that day 1 is directed towards healthcare providers. We invite patients and caregivers to attend day 2 on a complimentary basis. Please see additional details below. 

Day 1: Innovations in Brain Tumor Management

Day 1, Innovations in Brain Tumor Management, will provide an up-to-date review of neuro-oncology including a review of the most common primary brain tumors. An emphasis will be placed on cutting edge innovations in the management of brain tumors essential for practitioners managing neuro-oncology patients, including novel treatment approaches and upcoming biomarker evaluations such as CSF cell free DNA.

The target audience for day 1 includes physicians, trainees, and allied health professionals caring for patients with brain tumors. 

Day 2: Living with a Brain Tumor

Day 2, Living with a Brain Tumor, will provide attendees education and up-to-date information on medical, behavioral, and social implications of a brain tumor diagnosis. It will introduce the multidisciplinary care clinic (MDCC) and services available at MSK for patients and caregivers to address coping skills and improve quality of life after brain tumor diagnosis. In addition to lectures, the conference will include opportunities for interactive conversation between participants and faculty. View the day 2 brochure and agenda.

The target audience for day 2 includes patients with primary brain tumors, caregivers of patients with brain tumors, nurses, residents, fellows, neurologists, neuro-oncologists, social workers, rehabilitation medicine physicians, case managers, physical therapists and occupational therapists. 

MSK is pleased to invite patients and caregivers to attend day 2, Living with a Brain Tumor, on a complimentary basis. Attendees are welcome to join in person or view a live simulcast of the event. Please note that registration is required for either option and the live simulcast is only available for patients and caregivers (providers are invited to attend in person) 

If you are a patient or caregiver interested in attending, please email [email protected] for registration. Please include your name, email address, phone number and indicate whether you will be attending in person or prefer to view the live simulcast. 

This course is in collaboration with the National Brain Tumor Society.

1. Day 1: Update participants on specific types of brain tumors encountered in clinical practice including low-grade gliomas, glioblastoma, primary CNS lymphoma, and meningioma
2. Day 1: Provide a review of the most cutting edge new and emerging treatment strategies for brain tumors, including targeted therapies, immunotherapies, and CAR T-cell therapies
3. Day 1: Review new and updated strategies for neurosurgical and radiation treatments for gliomas and brain metastases
4. Day 2: Update participants on principle and rationale of clinical trials
5. Day 2: Learn about patient and caregiver services offered at MSK
6. Day 2: Introduce the multidisciplinary care clinic model-consisting of nurses, physical therapist, rehabilitation medicine doctor, nutritionist, case manager, social worker, and spiritual adviser.

Course registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration Discounts/Promotions

• MSK is pleased to invite patients and caregivers to attend day 2 on a complimentary basis. If you are a patient or caregiver interested in attending, [email protected] to register (registration is required in order to attend). Please include your name, email address, phone number and indicate whether you will be attending in person or prefer to view the live simulcast. 
• MSK CME offers a 30% discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course.

Please note: after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 9.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC CNE Statement*

Memorial Sloan Kettering Cancer Center – Nursing Professional  Development/Continuing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

3.10 CNE contact hours will be awarded to participants who attend a live program, in its entirety, and complete a program evaluation. Partial credit not awarded.

*Please note that ANCC CNE contact hours are only available for day 2. 

MSK Program Planning Committee

Day 1: Innovations in Brain Tumor Management

MSK Course Director (Day 1)

Thomas J. Kaley, MD
Director, Neuro-Oncology Fellowship Program 
Department of Neurology

Invited Course Faculty

Martin J. van den Bent, MD, PhD Director, Neuro-Oncology Program; Department of Neurology  The Brain Tumor Center at Erasmus MC Cancer Institute Christine Brown, PhD Associate Director, T Cell Therapeutics Research Laboratory;  Departments of Hematology & Hematopoietic Cell  Transplantation and Immuno-Oncology  City of Hope

Timothy F. Cloughesy, MD Director, Neuro-Oncology Program;  Department of Neurology  UCLA Health

MSK Course Faculty

 Day 2: Living with a Brain Tumor

MSK Course Director (Day 2)

Elena Pentsova, MD
Associate Director, Neuro-Oncology Fellowship Program
Department of Neurology

MSK Course Faculty

Ruth Kavanagh
Catherine Cronin 
David C. Cronin, MD, PhD, MHCM, FACS, FACHE
Sabine Schwab, PhD

Faculty Disclosures (All Faculty)